Scarica l'app Stockscreener
63.28
1.02%
0.64
Panoramica
Notizia
Cronologia dei prezzi
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Utah Medical Products Inc Borsa (UTMD) Ultime notizie
EPA moves to weaken pollution limits on chemical used to sterilize medical equipment - ABC4 Utah
Assessing Merit Medical Systems (MMSI) Valuation After Recent Share Price Weakness - simplywall.st
Medical ring-removal device invented by Nova Scotians gets a supporting role in HBO Max's The Pitt - PNI Atlantic News
Utah Medical Products Inc Stock Live Price, Chart, Analysis, News & Forecast – Buy, Sell & Trade US Equities Today - Mint
Mountain Lake Lodge Announces New Executive Leadership and Key Team Promotions - Weekly Voice
Global Minimally Invasive Surgical Devices Market to Witness Upsurge in Growth at a CAGR of ~7% by 2034 | DelveInsight - PR Newswire UK
UTMD (Utah Medical Products) NonCurrent Deferred Revenue : $0.00 Mil (As of Sep. 2025) - GuruFocus
UTMD SEC FilingsUtah Med Prods 10-K, 10-Q, 8-K Forms - Stock Titan
(UTMD) Risk Channels and Responsive Allocation - Stock Traders Daily
Quarterly Earnings: Can Utah Medical Products Inc stock outperform in a bear marketSwing Trade & Daily Profit Maximizing Tips - baoquankhu1.vn
Can Utah Medical Products Inc sustain its profitabilityQuarterly Earnings Summary & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Biomedical Gas Analyzers Market Size to Reach 3,500 USD Million by 2035, Growing at 5.4% CAGR - industrytoday.co.uk
Aug Movers: Can Utah Medical Products Inc outperform under higher oil prices2025 Market Overview & Daily Volume Surge Signals - baoquankhu1.vn
Analysis Recap: Is Utah Medical Products Inc stock undervalued right now2025 Bull vs Bear & Weekly High Potential Alerts - baoquankhu1.vn
Utah Medical Products (STU:UTM) 5-Year Dividend Growth Rate : 2.60% (As of Sep. 2025) - GuruFocus
Earnings Recap: Why is Utah Medical Products Inc stock going down2025 Momentum Check & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Utah Medical Products (STU:UTM) Altman Z-Score : 40.23 (As of Feb. 28, 2026) - GuruFocus
UTMD Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
(UTMD) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Electrosurgical Devices Market to Reach USD 10,220.04 Million by 2034, Growing at 6.34% CAGR | DelveInsight - openPR.com
Retail Trends: Is now the right time to enter RZLV2025 Fundamental Recap & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Utah Medical Products Inc (STU:UTM) Valuation: Modestly Overvalued - GuruFocus
Utah Medical Products (STU:UTM) Other Stockholders Equity : €0.00 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Treasury Stock : €0.00 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Retained Earnings : €109.02 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products Inc (STU:UTM) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Utah Medical Products (STU:UTM) Capital Expenditure : €-0.25 Mil (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Cash, Cash Equivalents, Mar - GuruFocus
Utah Medical Products (STU:UTM) Shareholder Yield % : 8.45% (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Median PS Value - GuruFocus
Utah Medical Products (STU:UTM) FCF Yield % : 6.53 (As of Feb. 25, 2026) - GuruFocus
Utah Medical Products (STU:UTM) Debt-to-Equity : 0.00 (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Inventories, Other : €0.00 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Long-Term Capital Lease Obl - GuruFocus
Utah Medical Products (STU:UTM) Minority Interest : €0.00 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Operating Income : €10.00 Mil (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) 10-Year ROIIC % : 2.08% (As of Dec. 2024) - GuruFocus
Utah Medical Products (STU:UTM) YoY Rev. per Sh. Growth : 0.50% (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Accounts Payable & Accrued Expense : €2.57 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Goodwill : €11.97 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Machinery, Furniture, Equipment : €0.00 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) ROIC % : 23.16% (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Short-Term Debt : €0.00 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) 3-Year ROIIC % : 22.67% (As of Dec. 2024) - GuruFocus
Utah Medical Products (STU:UTM) Sale Of Property, Plant, Eq - GuruFocus
Utah Medical Products (STU:UTM) EPS (Basic) : €3.05 (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Interest Coverage : N/A (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) EV-to-OCF : 8.64 (As of Feb. 23, 2026) - GuruFocus
Utah Medical Products (STU:UTM) Common Stock : €0.03 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Net Income From Continuing Operations : €10.35 Mil (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products Inc (STU:UTM) Competitors 2026 - GuruFocus
Utah Medical Products (STU:UTM) EBIT : €10.00 Mil (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Payments to Suppliers for G - GuruFocus
Utah Medical Products (STU:UTM) Non Operating Income : €1.51 Mil (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Total Operating Expense : €9.25 Mil (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Other Current Assets : €0.36 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Debt-to-Asset : 0.00 (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Inventories, Finished Goods : €1.04 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Other Net Income (Loss) : €-0.46 Mil (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Construction In Progress : €0.00 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Price-to-Tangible-Book : 2.07 (As of Feb. 23, 2026) - GuruFocus
Utah Medical Products (NASDAQ:UTMD) Stock Price Passes Above 200 Day Moving AverageWhat's Next? - MarketBeat
Is Utah Medical Products Inc. stock a buy or sellJuly 2025 Volume & Long Hold Capital Preservation Tips - mfd.ru
Liquidity Mapping Around (UTMD) Price Events - Stock Traders Daily
Utah Medical's Q4 earnings hurt by OEM decline, fall y/y - MSN
Can Utah Medical Products Inc. stock beat market expectations this quarterRecession Risk & Safe Capital Growth Trade Ideas - mfd.ru
Bear Alert: Will Greystone Housing Impact Investors LP stock recover after earningsWeekly Trend Report & Technical Pattern Recognition Alerts - baoquankhu1.vn
Utah Medical Products (NASDAQ:UTMD) Stock Crosses Above 200-Day Moving AverageShould You Sell? - MarketBeat
Can Utah Medical Products Inc. stock outperform in a bear market2025 Volatility Report & Accurate Entry and Exit Point Alerts - mfd.ru
Wall Street Recap: Will PZZA benefit from AI trendsEarnings Trend Report & Safe Entry Trade Signal Reports - baoquankhu1.vn
Patient Return Electrodes Market is expected to reach US$ 2.0 - openPR.com
Postpartum Hemorrhage Devices Market size to surpass $1.7 - openPR.com
Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.31 - Yahoo Finance
Trend Recap: Does GLUPRA outperform in volatile marketsTrade Entry Report & Expert-Curated Trade Recommendations - baoquankhu1.vn
0.97%
1.61%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):